JULIENNE KALA: Open Payments
NPI 1558911206 · HAGERSTOWN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$508 in 25 payments from 12 companies in 2025. Trend: 2023 $1,412 · 2024 $765 · 2025 $508
Food & beverage: $488Travel & lodging: $19
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 6 | $105 |
| Collegium Pharmaceutical, Inc. | 4 | $70 |
| BIOTRONIK NRO, Inc. | 3 | $58 |
| Valinor Pharma, LLC | 3 | $49 |
| Boston Scientific Corporation | 1 | $36 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $35 |
| TerSera Therapeutics LLC | 1 | $34 |
| MML US, Inc. | 1 | $29 |
| Averitas Pharma Inc. | 1 | $24 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $24 |
Products named: INCEPTIV, XTAMPZA, MOVANTIK, Prospera, WaveWriter Alpha Prime 16, JOURNAVX, Prialt, ReActiv8.
Industry payments across MD — which companies pay providers there.
